E. Zuckerkandl, About sympathetic paraganglions in the retroperitoneal space of man, Verh Anat Ges, vol.15, pp.95-107, 1901.

K. Unsicker, K. Huber, G. Schütz, and C. Kalcheim, The Chromaffin Cell and its Development, Neurochemical Research, vol.319, issue.6-7, pp.921-925, 2005.
DOI : 10.1007/s11064-005-6966-5

. Kohn, A: The paraganglia, Arch Mikrosk Anat, vol.52, pp.262-265, 1903.

A. Schober, R. Parlato, K. Huber, R. Kinscherf, B. Hartleben et al., Cell Loss and Autophagy in the Extra-Adrenal Chromaffin Organ of Zuckerkandl are Regulated by Glucocorticoid Signalling, Journal of Neuroendocrinology, vol.162, issue.1, pp.34-47, 2013.
DOI : 10.1007/BF00299978

G. West, D. Shepherd, R. Hunter, and A. Mcgregor, The function of the organs of Zuckerkandl, Clin Sci, vol.12, pp.317-325, 1953.

V. Martucci and K. Pacak, Pheochromocytoma and paraganglioma: Diagnosis, genetics, management, and treatment, Current Problems in Cancer, vol.38, issue.1, pp.7-41, 2014.
DOI : 10.1016/j.currproblcancer.2014.01.001
URL : http://europepmc.org/articles/pmc3992879?pdf=render

M. Lodish, K. Adams, T. Huynh, T. Prodanov, A. Ling et al., Succinate dehydrogenase gene mutations are strongly associated with paraganglioma of the organ of Zuckerkandl, Endocrine Related Cancer, vol.17, issue.3, pp.581-588, 2010.
DOI : 10.1677/ERC-10-0004

A. Subramanian and V. Maker, Organs of Zuckerkandl: their surgical significance and a review of a century of literature, The American Journal of Surgery, vol.192, issue.2, pp.224-234, 2006.
DOI : 10.1016/j.amjsurg.2006.02.018

M. Ayala-ramirez, L. Feng, M. Johnson, S. Ejaz, M. Habra et al., Clinical Risk Factors for Malignancy and Overall Survival in Patients with Pheochromocytomas and Sympathetic Paragangliomas: Primary Tumor Size and Primary Tumor Location as Prognostic Indicators, The Journal of Clinical Endocrinology & Metabolism, vol.96, issue.3, pp.717-725, 2011.
DOI : 10.1210/jc.2010-1946

Z. Zhuang, C. Yang, F. Lorenzo, M. Merino, T. Fojo et al., Gain-of-Function Mutations in Paraganglioma with Polycythemia, New England Journal of Medicine, vol.367, issue.10, pp.922-930, 2012.
DOI : 10.1056/NEJMoa1205119

A. Imperiale, F. Moussallieh, F. Sebag, L. Brunaud, A. Barlier et al., A New Specific Succinate-Glutamate Metabolomic Hallmark in Sdhx-Related Paragangliomas, PLoS ONE, vol.13, issue.11, p.80539, 2013.
DOI : 10.1371/journal.pone.0080539.t001
URL : https://hal.archives-ouvertes.fr/hal-01699803

M. Percy, P. Furlow, G. Lucas, X. Li, T. Lappin et al., Gene in Familial Erythrocytosis, New England Journal of Medicine, vol.358, issue.2, pp.162-168, 2008.
DOI : 10.1056/NEJMoa073123

D. Taïeb, C. Yang, B. Delenne, Z. Zhuang, A. Barlier et al., -Related Polycythemia-Paraganglioma Syndrome, The Journal of Clinical Endocrinology & Metabolism, vol.98, issue.5, pp.908-913, 2013.
DOI : 10.1210/jc.2013-1217

C. Yang, M. Sun, J. Matro, T. Huynh, S. Rahimpour et al., Novel HIF2A mutations disrupt oxygen sensing, leading to polycythemia, paragangliomas, and somatostatinomas, Blood, vol.121, issue.13, pp.2563-2566, 2013.
DOI : 10.1182/blood-2012-10-460972
URL : http://www.bloodjournal.org/content/bloodjournal/121/13/2563.full.pdf

K. Pacak, E. Chew, A. Pappo, C. Yang, F. Lorenzo et al., Ocular Manifestations of Hypoxia-Inducible Factor-2?? Paraganglioma-Somatostatinoma-Polycythemia Syndrome, Ophthalmology, vol.121, issue.11, pp.2291-2293, 2014.
DOI : 10.1016/j.ophtha.2014.06.019

K. Pacak, I. Jochmanova, T. Prodanov, C. Yang, M. Merino et al., New Syndrome of Paraganglioma and Somatostatinoma Associated With Polycythemia, Journal of Clinical Oncology, vol.31, issue.13, pp.1690-1698, 2013.
DOI : 10.1200/JCO.2012.47.1912

J. Welander, A. Andreasson, M. Brauckhoff, M. Bäckdahl, C. Larsson et al., Frequent EPAS1/HIF2?? exons 9 and 12 mutations in non-familial pheochromocytoma, Endocrine Related Cancer, vol.367, issue.10, pp.495-504, 2014.
DOI : 10.1056/NEJMoa1205119

I. Comino-méndez, A. De-cubas, C. Bernal, C. Álvarez-escolá, C. Sánchez-malo et al., Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis, Human Molecular Genetics, vol.125, issue.11, pp.2169-2176, 2013.
DOI : 10.1016/S0166-4328(01)00297-2

J. Favier, A. Buffet, and A. Gimenez-roqueplo, HIF2A mutations in paraganglioma with polycythemia, N Engl J Med, vol.367, pp.2161-2162, 2012.

B. Keith, R. Johnson, and M. Simon, HIF1?? and HIF2??: sibling rivalry in hypoxic tumour growth and progression, Nature Reviews Cancer, vol.1, issue.1, pp.9-22, 2011.
DOI : 10.1016/S1535-6108(02)00043-0